Trending Now
today
Welcome to Inside Wall Street, your home for all things economic, technical, and commercial.
headlines
around the world
spotlight
Clovis Oncology (CLVS), Sage Therapeutics (SAGE) and Puma Biotechnology (PBYI) could stoke acquisitive appetites in 2018 as large-cap biotechs struggle with slowing growth and major patent cliffs, analysts said Tuesday.
Deal-making has slowed since hitting a record high in 2015, RBC analysts said in a note to clients. The number...
